![DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11374/1/fig-1-full.png "DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]")
DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]
The Effect of EZH2 Inhibition through DZNep on Epithelial–Mesenchymal Transition Mechanism | Cellular Reprogramming
Cancers | Free Full-Text | Treatment Resistance Mechanisms of Malignant Glioma Tumor Stem Cells
DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice | Cell Death & Disease
Proposed mechanism by which DZNep epigenetically reactivates... | Download Scientific Diagram
3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation* - Journal of Biological Chemistry
Schematic representation of the mechanism of action of select histone... | Download Scientific Diagram
EZH2-inhibitor DZNep enhances apoptosis of renal tubular epithelial cells in presence and absence of cisplatin | Cell Division | Full Text
PRC2 subunit composition and modes of inhibition. Three types of... | Download Scientific Diagram
Frontiers | Histone Methylation Inhibitor DZNep Ameliorated the Renal Ischemia-Reperfusion Injury via Inhibiting TIM-1 Mediated T Cell Activation | Medicine
Cureus | Advances in Epigenetic Cancer Therapeutics
3-Deazaneplanocin,DZNep | CAS:102052-95-9 | Cell-permeable histone methyltransferase inhibitor | High Purity | Manufacturer BioCrick
A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep
Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells | Oncogenesis
3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells
DZNep and UNC0642 enhance in vitro developmental competence of cloned pig embryos in: Reproduction Volume 157 Issue 4 (2018)
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. - Abstract - Europe PMC
Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model | BMC Cancer | Full Text
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
![DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11374/1/fig-2-full.png "DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]")
DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]
3-Deazaneplanocin A hydrochloride (DZNep hydrochloride) | EZH2 Inhibitor | MedChemExpress
Molecular mechanisms involved in the synergistic interaction of DZNeP... | Download Scientific Diagram
DZNep inhibits histone methylation, reduces cellular Ezh2, and alters... | Download Scientific Diagram
Cureus | Advances in Epigenetic Cancer Therapeutics
3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells
Histone methylases as novel drug targets: developing inhibitors of EZH2 | Future Medicinal Chemistry
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML - ScienceDirect
Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis
Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells
